Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance

References

• Abdallah FM, Helmy MW, Katary MA, et al. (2018). Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Naunyn-Schmiedeberg's Arch Pharmacol 391:1399–410.
   Google Scholar
• Aleksakhina SN, Kashyap A, Imyanitov EN. (2019). Mechanisms of acquired tumor drug resistance. Biochim Biophys Acta Rev Cancer 1872:188310.
   PubMed Web of Science ®Google Scholar
• Aluri S, Janib SM, Mackay JA. (2009). Environmentally responsive peptides as anticancer drug carriers. Adv Drug Deliv Rev 61:940–52.
   PubMed Web of Science ®Google Scholar
• Arruebo M, Vilaboa N, Saez-Gutierrez B, et al. (2011). Assessment of the evolution of cancer treatment therapies. Cancers (Basel) 3:3279–330.
   PubMedGoogle Scholar
• Barati N, Momtazi‐Borojeni AA, Majeed M, et al. (2019). Potential therapeutic effects of curcumin in gastric cancer. J Cell Physiol 234:2317–28.
   PubMed Web of Science ®Google Scholar
• Bouramtane S, Bretin L, Pinon A, et al. (2019). Porphyrin-xylan-coated silica nanoparticles for anticancer photodynamic therapy. Carbohydr Polym 213:168–75.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.
   PubMed Web of Science ®Google Scholar
• Chen D, Dong X, Qi M, et al. (2017a). Dual pH/redox responsive and CD44 receptor targeting hybrid nano-chrysalis based on new oligosaccharides of hyaluronan conjugates. Carbohydr Polym 157:1272–80.
   PubMed Web of Science ®Google Scholar
• Chen D, Song X, Wang K, et al. (2017b). Design and evaluation of dual CD44 receptor and folate receptor-targeting double-smart pH-response multifunctional nanocarrier. J Nanopart Res 19: 1–11.
   Web of Science ®Google Scholar
• Chen L, Zheng J, Du J, et al. (2019). Folic acid-conjugated magnetic ordered mesoporous carbon nanospheres for doxorubicin targeting delivery. Mater Sci Eng C Mater Biol Appl 104:109939.
   PubMed Web of Science ®Google Scholar
• Dong X, Zou S, Guo C, et al. (2018). Multifunctional redox-responsive and CD44 receptor targeting polymer-drug nanomedicine based curcumin and alendronate: synthesis, characterization and in vitro evaluation. Artif Cells Nanomed Biotechnol 46:168–77.
   PubMed Web of Science ®Google Scholar
• Du Y, Bao C, Huang J, et al. (2019). Improved stability, epithelial permeability and cellular antioxidant activity of beta-carotene via encapsulation by self-assembled alpha-lactalbumin micelles. Food Chem 271:707–14.
   PubMed Web of Science ®Google Scholar
• Gomhor JAH, Kashanian S, Rafipour R, et al. (2018). Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells. Artif Cells Nanomed Biotechnol 46:S847–S854.
   PubMed Web of Science ®Google Scholar
• Greish K, Mathur A, Al Zahrani R, et al. (2018). Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer. J Control Release 291:184–95.
   PubMed Web of Science ®Google Scholar
• Houghton MJ, Kerimi A, Tumova S, et al. (2018). Quercetin preserves redox status and stimulates mitochondrial function in metabolically-stressed HepG2 cells. Free Radic Biol Med 129:296–309.
   PubMed Web of Science ®Google Scholar
• Ji X, Lu Y, Tian H, et al. (2019). Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother 114:108800.
   PubMed Web of Science ®Google Scholar
• Jia X, Ye HN, Weng H, et al. (2019). Small molecular target-based multifunctional upconversion nanocomposites for targeted and in-depth photodynamic and chemo-anticancer therapy. Mater Sci Eng C Mater Biol Appl 104:109849.
   PubMed Web of Science ®Google Scholar
• Kalyane D, Raval N, Maheshwari R, et al. (2019). Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C 98:1252–76.
   PubMed Web of Science ®Google Scholar
• Kundur S, Prayag A, Selvakumar P, et al. (2019). Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines. J Cell Physiol 234:11103–18.
   PubMed Web of Science ®Google Scholar
• Larasati YA, Yoneda-Kato N, Nakamae I, et al. (2018). Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep 8:2039.
   PubMed Web of Science ®Google Scholar
• Li W, Song K, Wang S, et al. (2019). Anti-tumor potential of astragalus polysaccharides on breast cancer cell line mediated by macrophage activation. Mater Sci Eng C Mater Biol Appl 98:685–95.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu WL, Guo J, et al. (2008). A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J Control Release 129:18–25.
   PubMed Web of Science ®Google Scholar
• Ma JJ, Yu YG, Yin SW, et al. (2018). Cellular Uptake and Intracellular Antioxidant Activity of Zein/Chitosan Nanoparticles Incorporated with Quercetin. J Agric Food Chem 66:12783–93.
   PubMed Web of Science ®Google Scholar
• Malorni L, Migliaccio I, Guarducci C, et al. (2017). Targeting the CDK4/6 pathway in breast cancer. Breast Cancer. 43:807–17.
   Google Scholar
• Maurya AK, Vinayak M. (2019). Improved synergistic anticancer efficacy of quercetin in combination with PI-103, rottlerin, and G0 6983 against MCF-7 and RAW 264.7 cells. In Vitro Celldevbiol-Animal 55:36–44.
   PubMed Web of Science ®Google Scholar
• Mrkus L, Batinic J, Bjelis N, et al. (2019). Synthesis and biological evaluation of quercetin and resveratrol peptidyl derivatives as potential anticancer and antioxidant agents. Amino Acids 51:319–29.
   PubMed Web of Science ®Google Scholar
• Mu Y, Fu Y, Li J, et al. (2019). Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug. Carbohydr Polym 203:10–8.
   PubMed Web of Science ®Google Scholar
• Namee NM, O'Driscoll L. (2018). Extracellular vesicles and anti-cancer drug resistance. Biochim Biophys Acta Rev Cancer 1870:123–36.
   PubMed Web of Science ®Google Scholar
• Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E. (2018). The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis 35:309–18.
   PubMed Web of Science ®Google Scholar
• Pilleron S, Sarfati D, Janssen-Heijnen M, et al. (2019). Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer 144:49–58.
   PubMed Web of Science ®Google Scholar
• Qi T, Chen B, Wang Z, et al. (2019). A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy. Biomaterials 213:119219.
   PubMed Web of Science ®Google Scholar
• Ren X, He L, Tian X, et al. (2019). pH and folic acid dual responsive polysaccharide nanospheres used for nuclear targeted cancer chemotherapy. Colloids Surf B Biointerfaces 178:445–51.
   PubMed Web of Science ®Google Scholar
• Reshma PL, Unnikrishnan BS, Preethi GU, et al. (2019). Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles. Int J Biol Macromol 136:266–74.
   PubMed Web of Science ®Google Scholar
• Seo SU, Woo SM, Lee H-S, et al. (2018). mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy. Oncogene 37:5205–20.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. (2019). Cancer statistics, 2019. CA A Cancer J Clin 69:7–34.
   PubMed Web of Science ®Google Scholar
• Song Z, Wen Y, Deng P, et al. (2019). Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. Carbohydr Polym 205:571–80.
   PubMed Web of Science ®Google Scholar
• Sun B, Chen Y, Yu H, et al. (2019). Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy. Acta Biomater 92:219–28.
   PubMed Web of Science ®Google Scholar
• Tahmasbi Rad A, Chen CW, Aresh W, et al. (2019). Combinational effects of active targeting, shape, and enhanced permeability and retention for cancer theranostic nanocarriers. ACS Appl Mater Interfaces 11:10505–19.
   PubMed Web of Science ®Google Scholar
• Tang Y, Soroush F, Tong Z, et al. (2017). Targeted multidrug delivery system to overcome chemoresistance in breast cancer. IJN 12:671–81.
   Web of Science ®Google Scholar
• Terlizzi M, Colarusso C, Pinto A, et al. (2019). Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness. Pharmacol Ther 202:140–8.
   PubMed Web of Science ®Google Scholar
• Tran TH, Nguyen AN, Kim JO, et al. (2016). Enhancing activity of artesunate against breast cancer cells via induced-apoptosis pathway by loading into lipid carriers. Artif Cells Nanomed Biotechnol 44:1979–87.
   PubMed Web of Science ®Google Scholar
• Wang B, Ma C, Guo C, et al. (2019a). Novel reductive responsive chrysin-oligomeric hyaluronic acid nanomaterials to curcumin delivery for cancer therapy. Sci Adv Mater 11:1376–82.
   Web of Science ®Google Scholar
• Wang D, Wang J, Huang H, et al. (2019b). Brush-shaped RAFT polymer micelles as nanocarriers for a ruthenium (II) complex photodynamic anticancer drug. Eur Polym J 113:267–75.
   Web of Science ®Google Scholar
• Wang K, Guo C, Dong X, et al. (2018a). In vivo evaluation of reduction-responsive alendronate-hyaluronan-curcumin polymer-drug conjugates for targeted therapy of bone metastatic breast cancer. Mol Pharmaceutics 15:2764–9.
   PubMed Web of Science ®Google Scholar
• Wang K, Guo C, Zou S, et al. (2018b). Synthesis, characterization and in vitro/in vivo evaluation of novel reduction-sensitive hybrid nano-echinus-like nanomedicine. Artif Cells Nanomed Biotechnol 46:659–67.
   PubMed Web of Science ®Google Scholar
• Wang K, Qi M, Guo C, et al. (2018c). Novel dual mitochondrial and CD44 receptor targeting nanoparticles for redox stimuli-triggered release. Nanoscale Res Lett 13:32.
   PubMed Web of Science ®Google Scholar
• Xu L, Jiang G, Chen H, et al. (2019a). Folic acid-modified fluorescent dye-protein nanoparticles for the targeted tumor cell imaging. Talanta 194:643–8.
   PubMed Web of Science ®Google Scholar
• Xu S, Wusiman A, Liu Z, et al. (2019b). pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity. Int J Biol Macromol 125:865–75.
   PubMed Web of Science ®Google Scholar
• Yao S, Chen L, Jia F, et al. (2019). Platinated porphyrin tailed with folic acid conjugate for cell-targeted photodynamic activity. J Lumin 214:116552.
   Web of Science ®Google Scholar
• Yoshikawa T, Mori Y, Feng H, et al. (2019). Rapid and continuous accumulation of nitric oxide-releasing liposomes in tumors to augment the enhanced permeability and retention (EPR) effect. Int J Pharm 565:481–7.
   PubMed Web of Science ®Google Scholar
• Yotsumoto K, Ishii K, Kokubo M, et al. (2018). Improvement of the skin penetration of hydrophobic drugs by polymeric micelles. Int J Pharm 553:132–40.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang B, Guo C, et al. (2019). Protoporphyrin IX-loaded laminarin nanoparticles for anticancer treatment, their cellular behavior, ROS detection, and animal studies. Nanoscale Res Lett 14:316.
   PubMed Web of Science ®Google Scholar
• Yu Y, Zou S, Wang K, et al. (2018). Synthesis, characterization and in vitro evaluation of dual pH/redox sensitive marine laminarin-based nanomedicine carrier biomaterial for cancer therapy. j Biomed Nanotechnol 14:1568–77.
   PubMed Web of Science ®Google Scholar
• Zhang W, Ma W, Zhang J, et al. (2017). The immunoregulatory activities of astragalus polysaccharide liposome on macrophages and dendritic cells. Int J Biol Macromol 105:852–61.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liang N, Gong X, et al. (2019). Tumor-targeting micelles based on folic acid and alpha-tocopherol succinate conjugated hyaluronic acid for paclitaxel delivery. Colloids Surf B Biointerfaces 177:11–8.
   PubMed Web of Science ®Google Scholar
• Zhao X, Ma H, Chen J, et al. (2019). An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy. Eur J Med Chem 182:111625.
   PubMed Web of Science ®Google Scholar